Trends in gastric cancer mortality in the US: A population-based analysis, 1999-2023.

M Maha Zafar (Roswell Park Comprehensive Cancer Center, Buffalo, NY) A Abdul Qadeer S Sardar Muhammad Imran Khan (NUMS, Rawalpindi , Pakistan) M Muneeb Khawar (King Edward Medical University, Lahore, Pakistan) M Muhammad Waqas H Hafsa Shahid (King Edward Medical University, Lahore, Pakistan) N Noor Fatima I Ikramah Saif (Nishtar Medical University, Multan, Pakistan) A Aiman Rehan (Oklahoma Health Sciences Center, Oklahoma, OK) M Mobeen Zaka Haider (West Virginia University, Morgantown, WV) A Aamir Laghari (Leigh Valley Health Network, Allentown, PA) R Robert W Kirchoff (Mayo Clinic Hospital, Pheonix, AZ)

Abstract

e16072 Background: Gastric cancer is a leading cause of mortality worldwide, with pronounced variations in outcomes across populations. This study investigates U.S. trends in age-adjusted mortality rates (AAMRs) for gastric cancer from 1999 to 2023, examining differences by gender, race, region, and urbanization to uncover critical patterns and inequities. Methods: Data were extracted from the CDC WONDER database using ICD-10 code C16 to identify gastric cancer-related deaths in adults aged 25 and older. AAMRs per 1,000,000 population were calculated and stratified by year, gender, race/ethnicity, geographic region, and urban-rural classification. Trends were analyzed using Joinpoint regression to determine annual percentage changes (APC) and 95% confidence intervals (CI). Statistical significance was set at p < 0.05. Results: From 1999 to 2023, there were 312,300 gastric cancer deaths (185,391 men, 126,909 women). Overall, AAMRs declined consistently, with APCs of -3.4 for the period 1999 to 2007, -2.2 for 2007 to 2018, and -1.2 for 2018 to 2023. Men showed a more pronounced decline, with APCs of -3.6 for 1999 to 2009 and -2.2 for 2009 to 2023, compared to women, who had APCs of -3.1 for 1999 to 2008, -1.9 for 2008 to 2018, and -0.8 for 2018 to 2023. Non-Hispanic Black populations experienced a decline in AAMR with an APC of -3.3 for 1999 to 2020, while Hispanic/Latino and Asian/Pacific Islander populations showed declines with APCs of -2.8 for 1999 to 2011 and -3.8 for 1999 to 2020, respectively. Metropolitan areas saw AAMR reductions with APCs of -3.3 for 1999 to 2008 and -2.2 for 2008 to 2020, while non-metropolitan areas had larger initial declines with an APC of -3.6 for 1999 to 2006 but slower decreases with an APC of -2.0 for 2006 to 2020. Geographically, the Northeast had the highest AAMR (62.9), followed by the West (61.7), South (57.4), and Midwest (50.9). Hawaii recorded the highest state-level AAMR (96.5), while Wyoming had the lowest (36.6). States in the top 90th percentile included Alaska, California, and New York, whereas Utah, Idaho, and Iowa were among the lowest. Conclusions: Gastric cancer mortality in the U.S. has declined over the past two decades, but the pace of reduction has slowed in recent years. Significant disparities persist across gender, racial, and geographic groups, underscoring the need for targeted interventions to address these inequities and improve outcomes in vulnerable populations.

Article Details

Volume / Issue Vol. 43, Issue 16_suppl
Published June 01, 2025
ISSN 0732-183X
Publisher Lippincott Williams & Wilkins

Journal Info

Journal of Clinical Oncology

Lippincott Williams & Wilkins

ISSN: 0732-183X Health Sciences

Authors (12)

M

Maha Zafar

Roswell Park Comprehensive Cancer Center, Buffalo, NY

A

Abdul Qadeer

S

Sardar Muhammad Imran Khan

NUMS, Rawalpindi , Pakistan

M

Muneeb Khawar

King Edward Medical University, Lahore, Pakistan

M

Muhammad Waqas

H

Hafsa Shahid

King Edward Medical University, Lahore, Pakistan

N

Noor Fatima

I

Ikramah Saif

Nishtar Medical University, Multan, Pakistan

A

Aiman Rehan

Oklahoma Health Sciences Center, Oklahoma, OK

M

Mobeen Zaka Haider

West Virginia University, Morgantown, WV

A

Aamir Laghari

Leigh Valley Health Network, Allentown, PA

R

Robert W Kirchoff

Mayo Clinic Hospital, Pheonix, AZ